BMC Geriatrics (Jan 2024)

Improving quality of life in the elderly: hearing loss treatment with cochlear implants

  • D. Cuda,
  • M. Manrique,
  • Á. Ramos,
  • M. Marx,
  • R. Bovo,
  • R. Khnifes,
  • O. Hilly,
  • J. Belmin,
  • G. Stripeikyte,
  • P. L. Graham,
  • C. J. James,
  • P. V. Greenham,
  • I. Mosnier

DOI
https://doi.org/10.1186/s12877-023-04642-2
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Background Hearing loss impacts health-related quality of life and general well-being and was identified in a Lancet report as one of the largest potentially modifiable factors for the prevention of age-related dementia. There is a lack of robust data on how cochlear implant treatment in the elderly impacts quality of life. The primary objective was to measure the change in health utility following cochlear implantation in individuals aged ≥ 60 years. Methods This study uniquely prospectively recruited a large multinational sample of 100 older adults (mean age 71.7 (SD7.6) range 60–91 years) with severe to profound hearing loss. In a repeated-measures design, pre and post implant outcome measures were analysed using mixed-effect models. Health utility was assessed with the Health Utilities Index Mark III (HUI3). Subjects were divided into groups of 60–64, 65–74 and 75 + years. Results At 18 months post implant, the mean HUI3 score improved by 0.13 (95%CI: 0.07–0.18 p 0.20). At baseline 90% of participants had no or mild depression and there was no change in mean depression scores after implant. Categories of Auditory perception scale showed that all subjects achieved a level of speech sound discrimination without lip reading post implantation (level 4) and at least 50% could use the telephone with a known speaker. Conclusions Better hearing improved individuals’ quality of life, ability to communicate verbally and their ability to function independently. They felt less lonely and less handicapped by their hearing loss. Benefits were independent of age group. Cochlear implants should be considered as a routine treatment option for those over 60 years with bilateral severe to profound hearing loss. Trial Registration ClinicalTrials.gov ( http://www.clinicaltrials.gov/ ), 7 March 2017, NCT03072862.

Keywords